ArticleBioengineering (Basel, Switzerland)2026
Clinically Robust Deep Learning for Contrast-Enhanced Mammography: Multicenter Evaluation Across Convolutional Neural Network Architectures.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigates the impact of anatomically constrained preprocessing and deep learning architecture selection on benign versus malignant breast lesion classification in contrast-enhanced mammography (CEM), with the goal of improving robustness and clinical reliability across heterogeneous data sources.
methodsIn this retrospective multicenter study, CEM images from 300 patients (314 lesions) were combined with 1003 publicly available CEM images, yielding a total of 1120 breast cases. Automatic breast segmentation was performed using the LIBRA framework to generate breast-mask images. Eleven deep learning models, including classical convolutional neural networks, attention-based networks, hybrid convolutional neural networks (CNNs), Transformer architectures, and mammography-specific models, were trained and evaluated using both original DICOM images and breast-mask inputs. Performance was assessed using accuracy, balanced accuracy, sensitivity, specificity, AUROC, and AUPRC on cross-validation and independent test sets. Hyperparameter optimization was conducted for the best-performing architecture.
resultsModels trained on breast-mask images consistently outperformed those trained on original DICOM images across all architectures and metrics, with AUROC improvements ranging from +0.06 to +0.21. Among all models, ResNet50 trained on breast-mask images achieved the best performance (AUROC = 0.931; AUPRC = 0.933; balanced accuracy = 0.834), further improved after optimization (balanced accuracy = 0.886; sensitivity = 0.842; specificity = 0.930). Classical CNN architectures demonstrated performance comparable to or exceeding that of more complex hybrid CNN-Transformer models when anatomically focused preprocessing and rigorous optimization were applied.
conclusionsAnatomically constrained preprocessing through breast-mask segmentation substantially enhances deep learning performance and stability in CEM-based breast lesion classification. These findings indicate that input representation quality and training optimization are critical determinants of clinically relevant performance, often outweighing architectural complexity, and may support more reliable AI-assisted decision support in CEM workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.